How is the HCW Biologics Inc today?

The HCW Biologics Inc today is trading in the down by -4.25% at 8.57.

What is HCW Biologics Inc Annual Revenue?

HCW Biologics Inc Annual Revenue fell 9.68%, in the last year to $2.57 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is HCW Biologics Inc Annual Net Profit?

HCW Biologics Inc Annual Net Profit fell 20.12% in the last year to $30.02 M. Its sector's average net profit growth for the last fiscal year was -11.05%.

What is HCW Biologics Inc Price to Earning Ratio?

HCW Biologics Inc Price to Earning Ratio is -0.32, which is negative.

What is HCW Biologics Inc Stock Price?

HCW Biologics Inc Stock Price fell 80.52% and underperformed its sector by 88.92% in the past year.

What is HCW Biologics Inc Quarterly Revenue?

HCW Biologics Inc Quarterly Revenue fell 70.18% YoY to $0.39 M. Its sector's average revenue growth YoY for the quarter was 3.12%.

What is HCW Biologics Inc Quarterly Net profit?

HCW Biologics Inc Quarterly Net profit rose 68.42% YoY to $3.37 M. Its sector's average net profit growth YoY for the quarter was -213.96%.

What is HCW Biologics Inc Return on Equity(ROE)?

HCW Biologics Inc Return on Equity(ROE) for the last financial year was -897.37%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is HCW Biologics Inc Mutual Fund Holding?

HCW Biologics Inc Mutual Fund Holding increased by 0.54% in the last quarter to 1.37.

What is HCW Biologics Inc Interest Coverage Ratio?

HCW Biologics Inc Interest Coverage Ratio is -24.92, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is HCW Biologics Inc Institutional Holding?

HCW Biologics Inc Institutional Holding increased by 0.48% in the last quarter to 7.28.

HCW Biologics Inc XNAS: HCWB

HCW Biologics Inc Live Share Price Today, Share Analysis and Chart

Name: HCW Biologics Inc: Is Infosys Ltd. worth buying?
Item: HCW Biologics Inc
Rating: 0.87550
Author: Trendlyne DVM scores

about

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The compa...

8.57 -0.38 (-4.25%)

91.50% Fall from 52W High

249.0K XNAS Volume

High vol.+gain this week

XNAS 19 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

8.0 / 100

Technically Bearish

27.0 / 100

120

1Yr Price target upside is 1300%

1 analysts

HCW Biologics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

HCW Biologics Inc FAQ

How is HCW Biologics Inc today?

HCW Biologics Inc today is trading in the red, and is down by -4.25% at 8.57.

How has HCW Biologics Inc performed historically?

HCW Biologics Inc is currently trading down -4.25% on an intraday basis. In the past week the stock rose 64.49%. stock has been down -45.06% in the past quarter and fell -80.52% in the past year. You can view this in the overview section.